Showing results (1141-1150 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|March 23, 2018
Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemiaRicardo García-Muñoz, Lorea Aguinaga, Jesus Feliu, et al.Immunotherapy|February 24, 2018
Malignant mesothelioma clinical trial combines immunotherapy drugsMonica S Chatwal, Tawee TanvetyanonImmunotherapy|June 7, 2022
Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream?Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.Immunotherapy|June 9, 2022
Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitorsAdi Kartolo, Cynthia Yeung, Wilma Hopman, et al.Immunotherapy|June 9, 2022
Therapeutics to tackle Omicron outbreakVivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu, et al.Immunotherapy|June 13, 2022
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1Daniel S Lefler, Adam E Snook, Babar BashirImmunotherapy|June 13, 2022
No association between BMI and immunotoxicity or clinical outcomes for immune checkpoint inhibitorsCynthia Yeung, Adi Kartolo, Ryan Holstead, et al.Immunotherapy|June 27, 2022
Safe use of intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer during breastfeeding: a case reportErol Barbur, Tunkut Doganca, Can ObekImmunotherapy|June 29, 2022
Immunology of osteoporosis: relevance of inflammatory targets for the development of novel interventionsSyed Sufian Ahmad, Faraha Ahmed, Ruhi Ali, et al.Immunotherapy|June 8, 2021
Current landscape of immunotherapy trials in locally advanced and high-risk head and neck cancerRobin Park, Jong Chul ParkPageof 188